Boughton Soleil 4
4 · Hims & Hers Health, Inc. · Filed Apr 22, 2026
Research Summary
AI-generated summary of this filing
Hims & Hers (HIMS) CLO Soleil Boughton Sells 9,463 Shares
What Happened
Soleil Boughton, Chief Legal Officer of Hims & Hers (HIMS), sold 9,463 shares on April 20, 2026 at $30.00 per share, for total proceeds of $283,890. This was a sale (disposition), not a purchase — sales by insiders are often routine and do not necessarily signal a change in company prospects.
Key Details
- Transaction date: April 20, 2026; filing date (Form 4): April 22, 2026 (filed timely).
- Trade: Sale of 9,463 shares at $30.00 each; total proceeds $283,890.
- Transaction code: S (sale); method indicated: open market or private sale.
- Shares owned after transaction: Not provided in the data supplied.
- Footnote: The sale was executed under a Rule 10b5-1 trading plan adopted by the reporting person on November 18, 2025.
Context
A 10b5-1 plan means the sale was preplanned and scheduled, which can reduce the likelihood the trade was based on nonpublic information. For retail investors: insider purchases tend to be more informative than routine sales, and this filing appears consistent with a prearranged selling plan rather than a discretionary trade.
Insider Transaction Report
- Sale
Class A Common Stock
[F1]2026-04-20$30.00/sh−9,463$283,890→ 299,368 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on November 18, 2025 by the Reporting Person.